CetroMed commercializes industry-driven research in medical technology, carried out at leading academical science institutions worldwide

The company identifies late-stage translational research projects in cutting-edge technologies and builds on accredited research, the early stages of which have already been funded by academical institutions including universities and medical schools. It acts as a bridge between academia and providers of venture capital and strategic finance, providing hands-on management expertise and investing or arranging seed capital for projects. Having identified suitable projects demonstrating both high science and important unmet needs in the company’s focus areas of Genomics, Therapeutics and Diagnostics, Cetromed typically commercializes the projects  through “spinning out” the technologies and relevant personnel into companies, co-owned with the key scientists and the primary research institutions, or through licensing arrangements with those institutions.

Cetromed - NetScientific